49 GLP-1RAs represent a pharmacotherapeutic category of injectable hypoglycemic agents that are sanctioned as adjunctive therapies to diet and exercise for the management of type 2 diabetes mellitus (T2DM) in adult patients and potentially hold promise in addressing other medical conditions
Among patients who qualified under existing indications, 74% had dyslipidemia, 62% had hypertension, 33% had prediabetes, 17% had obstructive sleep apnea, and 11% had cardiovascular disease
As a Center of Excellence designated by the Hypertrophic Cardiomyopathy Association, Wellstar is one of the leading providers of comprehensive HCM care in Metro Atlanta
Studies have revealed metabolic heterogeneity across different disease phases and clinical subtypes
In addition, secondary analyses were performed with 1:1 nearest-neighbor propensity score matching and an exact match for baseline variables differing by 20% between cohorts for each study population
The only thing I would complain about is the inconsistency between each pharmacy